Description & Mechanism AOD9604 is a synthetic peptide derived from the C-terminal fragment (residues 176191) of human growth hormone (hGH), with sequence modifications introduced to enhance stability and research utility
Tendon & ligament fibroblast cultures outgrowth rate, collagen organization, receptor expression
As of June 2026, none of the four peptides in KLOW are FDA-approved for the indications discussed in the research community
Directions: Take two capsules once per day or as directed by your medical provider
This difference in action is important because serotonin-targeting antidepressants often cause sexual side effects, including erectile dysfunction
2 At the July meeting, an FDA advisory committee will review several high-profile research-grade peptides including BPC-157, TB-500, KPV, and MOTs-C for possible inclusion on the 503A Bulks List, which would create a pathway for compounding under medical supervision